|
|
|
|
Family's praise for Carlisle hospital staff
Most people hate hospitals but for former pub landlady Joyce Harrison, Carlisles Cumberland Infirmary became a real home from home.The 69-year-old grandmother-of-three passed away on June 22 following a long illness, but her family have...
|
|
|
Motor abnormalities in premanifest persons with Huntington's disease: The PREDICT-HD study
Multiple linear regression associated total motor score, motor domains, and individual motor items with estimated diagnosis and striatal volumes Elevated total motor scores at baseline associated with higher genetic probability of disease...
|
|
|
Miracle of the drug that mends your faulty genes
Christine Falleti has spent much of her life combating the crippling effects of cystic fibrosis (CF).Now 34, she is painfully aware that she's approaching the age when most people with CF die. Two friends with the disease already have....
|
|
|
Risk Of Discrimination For Individuals With Family History Of Genetic Disease
A research published on reports that individuals with a family history of genetic disease are frequently discriminated by their relatives, friends and also by insurance companies.Many individuals have been able to adapt treatment and...
|
|
|
Risk Of Discrimination For Individuals With Family History Of Genetic Disease
A research published on reports that individuals with a family history of genetic disease are frequently discriminated by their relatives, friends and also by insurance companies.Many individuals have been able to adapt treatment and...
|
|
|
Individuals With Family History Of Genetic Disease At Risk Of Discrimination
People with a family history of genetic disease are often discriminated against by insurance companies and their relatives and friends, according to research published on the British Medical Journal website.Advances in genetic testing...
|
|
|
Individuals with family history of genetic disease at risk of discrimination
Research: Perceptions of genetic discrimination among people at risk for Huntingtons disease: a cross sectional survey, BMJ online People with a family history of genetic disease are often discriminated against by insurance companies and...
|
|
|
Individuals with family history of genetic disease at risk of discrimination
People with a family history of genetic disease are often discriminated against by insurance companies and their relatives and friends, according to research published on bmj.com today.Advances in genetic testing have meant that many...
|
|
|
Biovail to acquire tetrabenazine rights from Cambridge Labs
Biovail Corporation's wholly-owned subsidiary has entered into a definitive agreement to acquire worldwide development and commercialization rights to the entire portfolio of tetrabenazine products, including Xenazine/Nitoman (tetrabenazine...
|
|
|
Biovail Announces Acquisition of Worldwide Rights to Tetrabenazine
TORONTO--(BUSINESS WIRE)--Biovail Corporation (NYSE:BVF - News) (TSX:BVF - News) today announced a wholly owned subsidiary has entered into a definitive agreement to acquire worldwide development and commercialization rights to the entire...
|
|
|
Biovail buys worldwide drug rights
TORONTO Canadian pharmaceutical giant Biovail Corp.has acquired the worldwide rights to a drug used to treat chorea, a symptom of Huntingtons disease, in a deal worth $200 million US, the company announced Monday. The agreement,...
|
|
|
Biovail Announces Acquisition of Worldwide Rights to Tetrabenazine
This acquisition will be immediately accretive to revenues, margins and operating cash flows, and is anticipated to be moderately accretive to GAAP earnings per share in 2010.The transaction represents another solid step in our...
|
|
|
Biovail Receives 2009 Corporate Award from National Organization for Rare Disorders
TORONTO--(BUSINESS WIRE)--Biovail Corporation (NYSE: BVF - News)(TSX: BVF - News) today announced that the Company has received the 2009 Corporate Award from the National Organization for Rare Disorders (NORD) for the development of Xenazine...
|
|
|
Biovail Receives 2009 Corporate Award from National Organization for Rare Disorders
TORONTO -- (Business Wire) Biovail Corporation (NYSE: BVF)(TSX: BVF) today announced that the Company has received the 2009 Corporate Award from the National Organization for Rare Disorders (NORD) for the development of Xenazine for the...
|
|
|
Biovail earns $39-million (U.S.) in Q1 2009
a We are ahead of schedule with our New Strategic Focus and have proven our ability to execute,a said Biovail Chief Executive Officer Bill Wells.a We acquired and launched our first specialty CNS product, tetrabenazine for Huntingtona s ...
|
|
|
Biovail Reports First-Quarter 2009 Financial Results
Wellbutrin XL Acquisition Expected to Add $200-$220 Million to Cash Flows through 2010; Additional $480 Million Cash Expected through 2010 to Accelerate New Strategic Focus; Pimavanserin and Tetrabenazine CR Build on Specialty CNS Pipeline;...
|
|
|
Biovail Reports First-Quarter 2009 Financial Results
TORONTO--(BUSINESS WIRE)--Biovail Corporation (NYSE/TSX: BVF) today announced its financial results for the three-month period ended March 31, 2009.To the extent that this news release contains forward-looking statements, investors are...
|
